Belgian Banks Stock News

Viohalco went into this earnings print with a mixed setup. The stock had climbed roughly 17% over three months, yet slipped about 10% over the last month as investors questioned how much of the metals cycle was already priced in. The headline from these Q2 numbers is clear: profitability held up. Net income from continuing operations over the trailing twelve months came in at €288.1m, on €7.6b of revenue, and the P/E of 15.4x now sits between Belgian peers and the wider European Metals &...

Solvay reported a quarter with a 20% EBITDA decline, confirmed its full-year 2026 guidance, and in 2026 restarted its peroxide plant in Saudi Arabia while committing further capital to expand rare earth separation capacity at its La Rochelle site. A key differentiator is Solvay’s position as the only company outside China able to separate all 17 rare earth elements, which could prove important for customers seeking diversified supply chains. Next, we’ll examine how Solvay’s rare earth...

As European markets navigate the complexities of robust corporate earnings, heightened geopolitical tensions, and fluctuating oil prices, investors are keenly observing opportunities that may arise from these conditions. With the pan-European STOXX Europe 600 Index showing modest gains amid these developments, identifying undervalued stocks becomes crucial for those looking to capitalize on potential market inefficiencies. In this context, a good stock might be one that demonstrates strong...

Idaho investment puts Anheuser-Busch InBev ENXTBR:ABI supply chain in focus Anheuser-Busch InBev ENXTBR:ABI is putting fresh attention on its barley supply chain after announcing a $4 million investment in Idaho Falls operations and a $50,000 grant to the University of Idaho for barley research. See our latest analysis for Anheuser-Busch InBev. At a share price of €71.64, Anheuser-Busch InBev has a 90 day share price return of 12.22% and a year to date share price return of 31.69%. The 5 year...

As the pan-European STOXX Europe 600 Index edges higher amidst robust corporate earnings and geopolitical tensions, investors are closely monitoring the implications of rising oil prices and potential interest rate changes by the European Central Bank. In this dynamic environment, dividend stocks can offer a stable income stream, making them an attractive option for those looking to navigate market fluctuations while benefiting from regular payouts.

argenx (ENXTBR:ARGX) is back in focus after reporting half year 2026 earnings, with revenue of US$2.854b and net income of US$838m, supported by VYVGART and its expanded generalized myasthenia gravis reach. See our latest analysis for argenx. argenx's recent half year earnings and VYVGART label expansion have coincided with building momentum, with a 20.74% 90 day share price return and a 59.60% 1 year total shareholder return from a €804.4 share price today. If you are interested in other...

argenx (ENXTBR:ARGX) has put up another busy quarter, with Q2 2026 revenue at roughly US$1.5 billion and basic EPS of US$7.57, while trailing twelve month revenue sits at about US$5.3 billion and EPS at US$27.72, supported by net income of US$1.7 billion over that period. Over recent quarters the company has seen revenue move from US$967.63 million in Q2 2025 to US$1.54 billion in Q2 2026, alongside basic EPS stepping from US$4.02 to US$7.57. This sets the stage for investors to focus on how...

Econocom Group (ENXTBR:ECONB) has reported its H1 2026 results with revenue trends that have recently ranged from about €1.42 billion in H1 2025 to €1.50 billion in H2 2025, alongside basic EPS moving from €0.114 to €0.205 over the same period. This sets the stage for investors to focus on how those headline lines translate into underlying profitability. The company has seen total revenue move from €1.47 billion in H2 2024 to €1.50 billion in H2 2025, while trailing twelve month EPS values of...

Wereldhave Belgium (ENXTBR:WEHB) has posted its H1 2026 numbers with total revenue of €45.6 million and basic EPS of €3.01, giving investors fresh data to weigh against the trailing 12 month revenue of €85.9 million and EPS of €4.71. Over recent reporting halves, the company has seen revenue move from €39.0 million in H1 2025 to €40.3 million in H2 2025 and then to €45.6 million in H1 2026. Basic EPS shifted from €2.81 to €1.64 and now €3.01, setting up a results season where the key question...

Barco (ENXTBR:BAR) has opened H1 2026 reporting season with revenue of €454.4 million and basic EPS of €0.27 for the period, alongside trailing 12 month revenue of €927.6 million and basic EPS of €0.53. Over recent halves the company has seen revenue move from €512.1 million with EPS of €0.62 in H2 2024 to €454.4 million and €0.27 in H1 2025, before reaching €509.5 million and €0.58 in H2 2025. This sets up today’s release against a backdrop of shifting margins and a more demanding earnings...

Goldman Sachs has disclosed a new holding in Umicore (ENXTBR:UMI), crossing the 3% voting rights threshold. The stake was reported in a recent regulatory filing, confirming Goldman Sachs as a significant shareholder in the company. Umicore operates in materials technology and recycling, supplying key components for sectors such as batteries, automotive catalysts and specialty materials. The company is involved in long term themes related to electrification, resource efficiency and circular...

Cmb.Tech (ENXTBR:CMBT) drew fresh attention after agreeing with Fortescue to charter up to 12 ammonia capable Newcastlemax vessels, highlighting the company’s role in emerging low carbon shipping solutions. See our latest analysis for Cmb.Tech. The Fortescue charter news comes after a strong run in Cmb.Tech’s stock, with the share price at €13.22 and a year to date share price return of 64.02%, while the 1 year total shareholder return of 72.33% signals solid momentum on top of longer term...

Pixelworks, Inc. recently announced a partnership with Kinepolis Group to bring TrueCut Motion-enhanced versions of new theatrical releases to Kinepolis’ Laser Ultra premium large-format screens, aiming to deliver clearer, more immersive motion while preserving filmmakers’ intent. This collaboration highlights how Kinepolis is leaning on advanced motion-grading technology to differentiate its premium cinema offering and deepen the appeal of its high-end screens for moviegoers and content...

DEME Group (ENXTBR:DEME) has drawn fresh investor attention after committing to build a 22,000 m³ trailing suction hopper dredger, a sizeable fleet upgrade focused on productivity, cost efficiency, and lower greenhouse gas intensity. See our latest analysis for DEME Group. At a share price of €173.6, DEME Group has seen a 1-day share price return of 1.28%, while the 30-day and 90-day share price returns are down 5.03% and 8.63% respectively. However, the year to date share price return of...

In late June 2026, Wells Fargo named argenx a top Q3 tactical pick, highlighting an upcoming clinical catalyst as a key focus for investors. This endorsement brings fresh attention to how argenx’s pipeline progress and near-term milestones could influence expectations for its autoimmune portfolio. We’ll now examine how Wells Fargo’s Q3 tactical pick call and the looming clinical catalyst feed into argenx’s existing investment narrative. The future of work is here. Discover the 29 top...

As European markets continue to navigate mixed macroeconomic data and geopolitical developments, the pan-European STOXX Europe 600 Index has shown resilience with a modest gain. In this context, growth companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those who know the business best.

Readers hoping to buy Azelis Group NV ( EBR:AZE ) for its dividend will need to make their move shortly, as the stock...

UCB (ENXTBR:UCB) stock is in focus after new Brain Communications data on KYGEVVI for early onset TK2 deficiency highlighted improved survival and functional outcomes, along with acceptable tolerability in treated patients. See our latest analysis for UCB. The latest KYGEVVI data arrives as UCB shares trade at €255.0, with an 8.88% year to date share price return and a 51.64% total shareholder return over 1 year. This points to strong long term momentum alongside more modest recent gains. If...

CMB.TECH NV announced that it has signed a milestone agreement with Fortescue for the charter of up to 12 ammonia-capable Newcastlemax vessels, including up to three dual-fuel ammonia ships expected to enter service by the end of 2026. The deal highlights CMB.TECH’s growing role in advancing ammonia as a marine fuel, with the potential to materially cut shipping emissions if powered by green ammonia. Next, we’ll examine how this large-scale ammonia-capable charter agreement with Fortescue...

Cenergy Holdings SA ( EBR:CENER ), is not the largest company out there, but it received a lot of attention from a...

The resignation of Frederik Vandepitte as CEO of Cera Group and KBC Ancora, key anchor shareholders controlling over 41% of KBC Group (ENXTBR:KBC), puts governance and long term shareholder influence in sharper focus for investors. See our latest analysis for KBC Group. KBC Group’s recent share price return paints a mixed picture, with the stock down 0.7% on the day to €119.05 but recording a 7.4% 7 day and 9.4% 30 day share price return, alongside a 1 year total shareholder return of 46.3%...

The European Patent Office has upheld Solvay (ENXTBR:SOLB)’s key European patent covering its soda ash purge stream recycling process after a challenge from WE Soda Ltd, putting the company’s intellectual property position firmly in focus for investors. See our latest analysis for Solvay. Solvay’s recent patent win comes at a time when the stock’s 7-day share price return of 5.98% and 30-day share price return of 4.12% sit against a 1-year total shareholder return that is down 3.84%, while...

European markets have shown mixed performance recently, as investors navigate the European Central Bank's interest rate hikes and ongoing geopolitical tensions. Despite these challenges, there remains a keen interest in exploring investment opportunities within smaller or newer companies that may offer significant growth potential. While the term "penny stocks" may seem outdated, it continues to capture the essence of investing in companies with lower market capitalizations that could present...

Earlier in June 2026, ELIQUENT Life Sciences announced that UCB went live with the full Veeva Safety Suite, consolidating its global pharmacovigilance operations into a single cloud-based platform delivered in collaboration with Veeva, Pinnaxis, and Daelight Solutions. Separately, UCB and Biogen presented Phase 3 PHOENYCS GO data at EULAR 2026 suggesting dapirolizumab pegol may help systemic lupus erythematosus patients sustain disease control while reducing long-term steroid exposure,...